Literature DB >> 29428666

MicroRNA-519d inhibits proliferation and induces apoptosis of human hypertrophic scar fibroblasts through targeting Sirtuin 7.

Xiaoqian Zhou1, Yidun Xie2, Houan Xiao3, Xudong Deng3, Yu Wang3, Liyuan Jiang3, Chen Liu3, Rui Zhou3.   

Abstract

MicroRNAs (miRNAs) play critical roles in various pathological processes, including hypertrophic scar (HS) formation. However, the precise role of miRNAs in HS formation remains largely unknown. In this study, we aimed to investigate the role of miR-519d in HS formation. We found that miR-519d expression was significantly downregulated in HS tissues and fibroblasts. Overexpression of miR-519d inhibited the expression of type I collagen (Col I), type III collagen (Col III) and α-smooth muscle actin (α-SMA) in HS fibroblasts. Moreover, overexpression of miR-519d reduced the proliferation and induced the apoptosis of HS fibroblasts. In contrast, suppression of miR-519d showed the opposite effects. Interestingly, Sirtuin 7 (SIRT7) was identified as a target gene of miR-519d. The results showed that miR-519d directly targeted the 3'-untranslated region of SIRT7 and negatively regulated its expression. Furthermore, miR-519d regulated the expression of TGF-β type I receptor (TGFBRI) and the phosphorylation of Smad2. Knockdown of SIRT7 by siRNA inhibited the expression of Col I, Col III and α-SMA, and reduced the proliferation and induced the apoptosis of HS fibroblasts. Overexpression of SIRT7 abrogated the effects mediated by miR-519d overexpression in HS fibroblasts. Overall, these results suggest that miR-519d inhibits the expression of extracellular matrix-associated genes, reduces the proliferation and induces the apoptosis of HS fibroblasts by targeting SIRT7, implying a suppressive role of miR-519d in HS formation. This study suggests that miR-519d may serve as a promising therapeutic target for treatment of human HS.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Fibroblast; Hypertrophic scar; SIRT7; miR-519d

Mesh:

Substances:

Year:  2018        PMID: 29428666     DOI: 10.1016/j.biopha.2018.01.158

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  10 in total

1.  MiR-519d-5p modulates the sensitivity of breast cancer to chemotherapy by forming a negative feedback loop with RELA.

Authors:  Ding Li; Tingting Wang; Zelei Yu; Yi Zhang; Xuan Wu; Ning Zheng; Wenzhou Zhang; Lixian Wu
Journal:  Ann Transl Med       Date:  2021-07

2.  Inhibition of sphingosine kinase 2 attenuates hypertrophic scar formation via upregulation of Smad7 in human hypertrophic scar fibroblasts.

Authors:  Jian Zeng; Bin Jiang; Xia Xiao; Rou Zhang
Journal:  Mol Med Rep       Date:  2020-07-09       Impact factor: 2.952

3.  miR-495 inhibits the growth of fibroblasts in hypertrophic scars.

Authors:  Bingyu Guo; Qiang Hui; Zhishan Xu; Peng Chang; Kai Tao
Journal:  Aging (Albany NY)       Date:  2019-05-14       Impact factor: 5.682

4.  Cuprous oxide nanoparticles reduces hypertrophic scarring by inducing fibroblast apoptosis.

Authors:  Yongqiang Xiao; Dayuan Xu; Hongyuan Song; Shichu Xiao; Futing Shu; Pei Wei; Xiaolan Yang; Chenjian Zhong; Xiaohong Wang; Werner Eg Müller; YongJun Zheng; Zhaofan Xia
Journal:  Int J Nanomedicine       Date:  2019-07-30

5.  MicroRNA-9-5p inhibits proliferation and induces apoptosis of human hypertrophic scar fibroblasts through targeting peroxisome proliferator-activated receptor β.

Authors:  Chi-Yung Chai; I-Chun Tai; Rui Zhou; Junlong Song; Chaoying Zhang; Shengrong Sun
Journal:  Biol Open       Date:  2020-12-21       Impact factor: 2.422

6.  Inhibition of CUB and sushi multiple domains 1 (CSMD1) expression by miRNA-190a-3p enhances hypertrophic scar-derived fibroblast migration in vitro.

Authors:  Shuchen Gu; Xin Huang; Xiangwen Xu; Yunhan Liu; Yimin Khoong; Zewei Zhang; Haizhou Li; Yashan Gao; Tao Zan
Journal:  BMC Genomics       Date:  2021-08-12       Impact factor: 3.969

7.  Circular RNA HECTD1 knockdown inhibits transforming growth factor-beta/ small mothers against decapentaplegic (TGF-β/Smad) signaling to reduce hypertrophic scar fibrosis.

Authors:  Xiaojing Ge; Yute Sun; Youzhi Tang; Jing Lin; Fang Zhou; Gang Yao; Xin Su
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

Review 8.  Is the future scarless? - Fibroblasts as targets for scarless wound healing: a narrative review.

Authors:  Dylan Parry; Keith Allison
Journal:  Scars Burn Heal       Date:  2022-09-01

9.  BMS-202, a PD-1/PD-L1 inhibitor, decelerates the pro-fibrotic effects of fibroblasts derived from scar tissues via ERK and TGFβ1/Smad signaling pathways.

Authors:  Yuanyuan Cai; Min Xiao; Xinqing Li; Shanyu Zhou; Yangyang Sun; Wenyuan Yu; Tianlan Zhao
Journal:  Immun Inflamm Dis       Date:  2022-10

Review 10.  The Emerging Therapeutic Targets for Scar Management: Genetic and Epigenetic Landscapes.

Authors:  Sara Amjadian; Sharif Moradi; Parvaneh Mohammadi
Journal:  Skin Pharmacol Physiol       Date:  2022-06-13       Impact factor: 3.014

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.